Suppr超能文献

欧洲将人乳头瘤病毒疫苗纳入国家免疫计划的现状:VENICE2 2010 调查的初步结果。

The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey.

机构信息

Department of Infectious Diseases, Institut de Veille Sanitaire (InVS, French Institute for Public Health Surveillance), Paris, France.

出版信息

Euro Surveill. 2010 Nov 25;15(47):19730. doi: 10.2807/ese.15.47.19730-en.

Abstract

The Venice 2 human papillomavirus vaccination survey evaluates the state of introduction of the HPV vaccination into the national immunisation schedules in the 29 participating countries. As of July 2010, 18 countries have integrated this vaccination. The vaccination policy and achievements vary among those countries regarding target age groups, delivery infrastructures and vaccination coverage reached. Financial constraints remain the major obstacle for the 11 countries who have not yet introduced the vaccination.

摘要

《威尼斯 2 人乳头瘤病毒疫苗接种调查》评估了 29 个参与国家将 HPV 疫苗纳入国家免疫计划的情况。截至 2010 年 7 月,已有 18 个国家将该疫苗纳入计划。在目标年龄组、提供基础设施和接种覆盖率方面,各国的疫苗接种政策和成果各不相同。11 个尚未引入疫苗的国家仍面临着财政限制这一主要障碍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验